Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.1%

2 terminated/withdrawn out of 22 trials

Success Rate

84.6%

-1.9% vs industry average

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

27%

3 of 11 completed trials have results

Key Signals

7 recruiting3 with results

Enrollment Performance

Analytics

N/A

8(53.3%)

Phase 2

3(20.0%)

Phase 3

2(13.3%)

Phase 1

1(6.7%)

Phase 4

1(6.7%)

15Total

N/A(8)

Phase 2(3)

Phase 3(2)

Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials

NCT06568549Phase 4Recruiting

Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.

Role: collaborator

NCT07133334Completed

Evaluation and Comparison of the Benefits of Routine vs Shampoo Alone During 4 Weeks Treatment and 12 Weeks Remanence

Role: collaborator

NCT06538961Recruiting

Immune Registry for BK in Kidney Transplant Recipients

Role: collaborator

NCT07193394Phase 2Recruiting

Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer

Role: collaborator

NCT05595837Completed

Immune Registry for Organ Transplantation From COVID Positive Donors.

Role: collaborator

NCT07107854Completed

EVALUATION OF THE EFFICACY OF COSMETIC PRODUCT IN ADULTS SUBJECTS WITH MILD TO MODERATE ACNE

Role: collaborator

NCT03576417Phase 3Active Not Recruiting

A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck

Role: collaborator

NCT06263114Terminated

Correlation of Blood Gene Expression (TruGraf Liver) With Liver Biopsy in Pediatric Liver Transplant Recipients

Role: collaborator

NCT06727292Not ApplicableRecruiting

Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo

Role: collaborator

NCT05821296Not ApplicableCompleted

Evaluation of Efficacy and Tolerance of Crystal Peel in the Treatment of Adults Presenting Facial Mild Acne

Role: collaborator

NCT06268847Not ApplicableCompleted

Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms

Role: collaborator

NCT06333782Not ApplicableRecruiting

Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation

Role: collaborator

NCT02156401Recruiting

VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE

Role: collaborator

NCT06254027Not ApplicableUnknown

Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment

Role: collaborator

NCT03458221Phase 2Recruiting

Signal TrAnsduction Pathway Activity Analysis in OVarian cancER

Role: collaborator

NCT04813614Not ApplicableCompleted

Effectiveness and Safety of STYLAGE® M Lidocaïne for Lips' Volume Augmentation and/or Redefinition of the Outline of the Lips (SMILE)

Role: collaborator

NCT04465916Phase 2Terminated

Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)

Role: collaborator

NCT04490850Not ApplicableCompleted

COVID-19 Seroprevalence Study in French Guiana

Role: collaborator

NCT04685096Completed

Anti-ageing Efficacy of a Cosmetic Formulation Containing NMN (2%) Versus Placebo

Role: collaborator

NCT01297959Phase 3Completed

Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery

Role: collaborator